HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD

Andere Sprachen Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Aktien

301126

CNE1000054V3

301126

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 07.06.2024			% 5 Tage	% 1. Jan.
9,15 ^CNY	+4,69 %		-6,06 %	-29,78 %

05.06.	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) beginnt im Rahmen der am 15. April 2024 erteilten Ermächtigung einen Aktienrückkauf im Wert von CNY 15 Millionen.	CI
22.04.	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd commences an Equity Buyback for CNY 15 million worth of its shares, under the authorization approved on April 15, 2024.	05.06.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	22.05.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Cash Dividend for 2023	15.05.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	22.04.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding	28.03.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	24.10.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Board Elections	11.10.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed the share acquisition agreement to acquire 51% stake in Shanxi Simaile Pharmaceutical Chain Co., Ltd. from Yang Jinjiang, Liu Hongming for approximately CNY 330 million.	19.09.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	28.08.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd agreed to acquire Yinchuan Meihetai Pharmaceutical Chain Co., Ltd. from Xie Huiyang and Xie Xiaolong for approximately CNY 250 million.	04.07.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Implements Final Cash Dividend of A Shares for the Year 2022, Payable on June 12, 2023	02.06.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Final Cash Dividend for 2022	15.05.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd cancelled the transaction announced on May 18, 2022	28.04.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 300 million in funding	28.04.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Proposes Final Cash Dividend for the Year 2022	24.04.23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	21.04.23
Hunan Tongjian Pharmacy to Buy 86% Stake in Local Peer For 341 Million Yuan	03.01.23
Hunan Tongjian Pharma to Buy 86% of Local TCM Maker For 341 Million Yuan	23.12.22
Certain A Shares of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022.	08.12.22
Hunan Dajiaweikang Pharma to Buy 85.7% Stake in Pharma Firm	16.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Aktien

301126

CNE1000054V3

301126

Andere Sprachen

Filter